Concepedia

Leonard Buckbinder

LB

Statistics

Publications

37

Citations

3.8K

H-Index

30

Active since

1985

Affiliations

Pfizer (United States)(Current)

Environmental and Occupational Health Sciences Institute

Bristol-Myers Squibb (United States)

Johnson University

Bristol-Myers Squibb (Germany)

Leonard Buckbinder is an author at Pfizer (United States) specializing in life sciences, molecular biology, and pharmacology.

ORCID

Publications per year

1985–2023

37

Publications

37

Induction of the growth inhibitor IGF-binding protein 3 by p53

Leonard Buckbinder, Randy Talbott, Susana Velasco-Miguel et al. · Nature · 1995 · 877 citations

, , +10

NF-κB RelA Phosphorylation Regulates RelA Acetylation

Lin‐Feng Chen, Samuel A. Williams, Yajun Mu et al. · Molecular and Cellular Biology · 2005 · 437 citations · Full text

, , +16

PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes

Susana Velasco-Miguel, Leonard Buckbinder, Patrice Jean et al. · Oncogene · 1999 · 255 citations

, , +14

The initiator directs the assembly of a transcription factor IID-dependent transcription complex.

Juan M. Cárcamo, Leonard Buckbinder, Danny Reinberg · Proceedings of the National Academy of Sciences · 1991 · 169 citations

, , +17

Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis

Leonard Buckbinder, David T. Crawford, Hong Qi et al. · Proceedings of the National Academy of Sciences · 2007 · 157 citations · Full text

, , +17

1–5 of 37